検索結果一覧

一般口演 / Oral Session

【E】一般口演 24 (Oral Session 24) :Basic Research 2(Myeloma Novel Agents)
 
日程
2013年10月11日(金)
時間
15:25 - 16:25
会場
第6会場 / Room No.6 (ロイトン札幌 2F エンプレス)
座長・司会
尾崎 修治 (Shuji Ozaki):1
1:Department of Hematology, Tokushima Prefectural Central Hospital, Japan

前へ戻る


Endoplasmic reticulum stress-related gene expression can predict response to bortezomib in myeloma

演題番号 : OS-1-120

成田 朋子 (Tomoko Narita):1、李 政樹 (Masaki Ri):1、正木 彩子 (Ayako Masaki):1、森 芙美子 (Fumiko Mori):1、伊藤 旭 (Asahi Ito):1、楠本 茂 (Shigeru Kusumoto):1、石田 高司 (Takashi Ishida):1、小松 弘和 (Hirokazu Komatsu):1、新実 彰男 (Akio Niimi):1、飯田 真介 (Shinsuke Iida):1

1:Nagoya City University School of Medical Sciences Department of Medical Oncology and Immunology, Japan

Endoplasmic reticulum stress-related gene expression can predict response to bortezomib in myeloma

Bone restoration and tumor suppression in myeloma by cathepsin K inhibition with bortezomib

演題番号 : OS-1-121

渡邉 佳一郎 (Keiichiro Watanabe):1,2、安倍 正博 (Masahiro Abe):1、森 裕史 (Hiroshi Mori):3、宇高 憲吾 (Kengo Udaka):1、岩佐 昌美 (Masami Iwasa):1、Derek Hanson:1、天知 良太 (Ryota Amachi):1,4、日浅 雅博 (Masahiro Hiasa):1,4,5、原田 武志 (Takeshi Harada):1、藤井 志朗 (Shiro Fujii):1、中村 信元 (Shingen Nakamura):1、三木 浩和 (Hirokazu Miki):1、賀川 久美子 (Kumiko Kagawa):1、遠藤 逸朗 (Itsuro Endo):1、田中 栄二 (Eiji Tanaka):4、松本 俊夫 (Toshio Matsumoto):1

1:Dept. Medicine and Bioregulatory Sci., Tokushima Univ, Japan、2:Dept. Orthodontics, Tokushima Univ Hospital, Japan、3:Minase Res. Ins., ONO Pharm. Co., LTD., Osaka, Japan、4:Dept. Orthodontics and Dentofacial Orthopedics, Tokushima Univ, Japan、5:Dept. Biomaterials and Bioengineerings, Tokushima Univ, Japan

Bone restoration and tumor suppression in myeloma by cathepsin K inhibition with bortezomib

Bortezomib induces Schwann cell injury due to the activation of autophagy_lysosomal system

演題番号 : OS-1-122

鈴木 ちぐれ (Chigure Suzuki):1、向井 陽美 (Harumi Mukai):2、内山 安男 (Yasuo Uchiyama):1

1:Dept of Cell Biology and Neurosciences, Juntendo Univ,Japan、2:Janssen Pharmaceutical K.K. Scientific Affairs Div., Tokyo, Japan

Bortezomib induces Schwann cell injury due to the activation of autophagy_lysosomal system

CKD-581, a novel histone deacetylase inhibitor, synergistically enhances Bortezomib cytotoxicity in multiple myeloma cells

演題番号 : OS-1-123

Ji Hyun Kwon:1,2、Youngil Koh:1、Chan-Soo Lee:2、Ji-Hye Choi:2、Kwang-Sung Ahn:2、Ji-Won Kim:1、Hyun-Jung Lee:3、Sung-Soo Yoon:1,2

1:Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea、2:Cancer Research Institute, Seoul National University College of Medicine, Seoul , Korea、3:Department of Internal Medicine, Dongguk University Ilsan Medical Center, Kyungki, Korea

CKD-581, a novel histone deacetylase inhibitor, synergistically enhances Bortezomib cytotoxicity in multiple myeloma cells

Targeting clonogenic myeloma cells by defucosylated anti-HM1.24 in combination with lenalidomide

演題番号 : OS-1-124

原田 武志 (Takeshi Harada):1、尾崎 修治 (Shuji Ozaki):2、小田 明日香 (Asuka Oda):1、辻 大輔 (Daisuke Tsuji):3、岩佐 昌美 (Masami Iwasa):1、藤井 志朗 (Shiro Fujii):1、中村 信元 (Shingen Nakamura):1、三木 浩和 (Hirokazu Miki):1,4、賀川 久美子 (Kumiko Kagawa):1、柴田 泰伸 (Hironobu Shibata):2、重清 俊雄 (Toshio Shigekiyo):2、伊藤 孝司 (Kohji Itoh):3、川合 重人 (Shigeto Kawai):5、岡部 尚文 (Hisafumi Okabe):6、松本 俊夫 (Toshio Matsumoto):1、安倍 正博 (Masahiro Abe):1

1:Department of Medicine and Bioregulatory Sciences, Tokushima University, Tokushima, Japan、2:Department of Hematology, Tokushima Prefectural Central Hospital, Tokushima, Japan、3:Department of Medical Biotechnology, Graduate School of Pharmaceutical Sciences, University of Tokushima, Tokushima, Japan、4:Division of Transfusion Medicine, Tokushima University Hospital, Tokushima, Japan、5:Forerunner Pharma Research, Tokyo, Japan、6:Research Division, Chugai Pharmaceutical Co. Ltd., Kanagawa, Japan

Targeting clonogenic myeloma cells by defucosylated anti-HM1.24 in combination with lenalidomide